# EDGAR Filing Document

**Accession Number:** 0001113169
**File Stem:** 0001628280-26-005273
**Filing Date:** 2026-2
**Character Count:** 58089
**Document Hash:** 53a6a2b9feeeab25549f72bc502fa780
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-005273.hdr.sgml**: 20260204

**ACCESSION NUMBER**: 0001628280-26-005273

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260204

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260204

**DATE AS OF CHANGE**: 20260204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRICE T ROWE GROUP INC
- **CENTRAL INDEX KEY:** 0001113169
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 522264646
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-32191
- **FILM NUMBER:** 26596010

**BUSINESS ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231
- **BUSINESS PHONE:** 4103452000

**MAIL ADDRESS:**
- **STREET 1:** HARBOR POINT
- **STREET 2:** 1307 POINT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21231

?xml version='1.0' encoding='ASCII'? trow-20260204

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

___________________________

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): February 4, 2026** 

**<u>T. Rowe Price Group, Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **<u>Maryland</u>** | **<u>000-32191</u>** | **<u>52-2264646</u>** |
| (State of <br>incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**<u>1307 Point Street, Baltimore, Maryland 21231</u>**

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: **<u>(410) 345-2000</u>**

N/A

(Former Name of Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, par value $0.20 | TROW | The NASDAQ Stock Market LLC <br>(Nasdaq Global Select Market) |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12-2 of this chapter).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Section 2 - Financial Information.**

**Item 2.02. Results of Operations and Financial Condition.**

On February 4, 2026 we issued an earnings release reporting our results of operations for the three and twelve months ended December 31, 2025. A copy of this earnings release is attached hereto as Exhibit 99.1 and is incorporated by reference.

The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

**Section 9 - Financial Statements and Exhibits.**

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[99.1 Earnings Release dated](earningsreleaseq42025.htm)[February](earningsreleaseq42025.htm)[4](earningsreleaseq42025.htm)[, 202](earningsreleaseq42025.htm)[6](earningsreleaseq42025.htm)

104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

**T. Rowe Price Group, Inc.**

By: <u>/</u><u>s</u><u>/ Jennifer B. Dardis</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jennifer B. Dardis

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vice President, Chief Financial Officer and Treasurer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date: February 4, 2026

## Ex-99

![trustee-2023.gif](trustee-2023.gif)

**NEWS RELEASE**

**T. ROWE PRICE GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS**

BALTIMORE (February 4, 2026) - T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) today reported its results for the fourth quarter and full year of 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**▪ Assets under management (AUM) of $1.8 trillion at December 31, 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪* Net client outflows of $25.5 billion for Q4 2025 and $56.9 billion for 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪* Diluted earnings per common share (EPS) of $1.99 for Q4 2025 and $9.24 for 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪* Adjusted diluted EPS of $2.44 for Q4 2025 and $9.72 for 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**▪ Returned $426 million in Q4 2025 and $1.8 billion in 2025 to stockholders from the recurring quarterly dividend and stock repurchases**

Rob Sharps, chair, CEO, and president, commented, "In 2025, we made solid progress across our strategic initiatives. We entered new partnerships to extend our reach and grew our ETFs and alternatives business to position the firm for long-term success."

**Financial Highlights** 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three months ended | Three months ended | Three months ended | Three months ended | Three months ended | Year ended | Year ended | Year ended |
| (in millions, except per-share data) | 12/31/2025 | 12/31/2024 | Change<sup>(1)</sup> | 9/30/2025 | Change<sup>(1)</sup> | 12/31/2025 | 12/31/2024 | Change<sup>(1)</sup> |
| **<u>U.S. GAAP basis</u>** |  |  |  |  |  |  |  |  |
| Investment advisory fees | $1737.6 | $1667.2 | 4.2% | $1698.7 | 2.3% | $6602.3 | $6399.7 | 3.2% |
| Capital allocation-based income<sup>(2)</sup> | $40.8 | $(5.2) | n/m | $42 | n/m | $81.2 | $46.6 | 74.2% |
| Net revenues | $1934.1 | $1824.5 | 6.0% | $1893.5 | 2.1% | $7314.8 | $7093.6 | 3.1% |
| Operating expenses | $1463.1 | $1256.1 | 16.5% | $1250.3 | 17.0% | $5126 | $4760.3 | 7.7% |
| Net operating income | $471 | $568.4 | (17.1)% | $643.2 | (26.8)% | $2188.8 | $2333.3 | (6.2)% |
| Non-operating income (loss) | $142.1 | $4.6 | n/m | $238.4 | n/m | $686.7 | $486.3 | 41.2% |
| Net income - T. Rowe Price Group, Inc. | $445.3 | $439.9 | 1.2% | $646.1 | (31.1)% | $2087.1 | $2100.1 | (0.6)% |
| Diluted earnings per common share | $1.99 | $1.92 | 3.6% | $2.87 | (30.7)% | $9.24 | $9.15 | 1.0% |
| **<u>Adjusted basis</u>**<sup>(3)</sup> |  |  |  |  |  |  |  |  |
| Operating expenses | $1249.8 | $1222.6 | 2.2% | $1134.4 | 10.2% | $4666.5 | $4498.8 | 3.7% |
| Operating expenses, excluding accrued carried interest related compensation | $1231.1 | $1218.7 | 1.0% | $1111.8 | 10.7% | $4608 | $4456.3 | 3.4% |
| Net operating income | $691.7 | $620.2 | 11.5% | $774.1 | (10.6)% | $2720.8 | $2685.9 | 1.3% |
| Non-operating income (loss) | $44.7 | $34.3 | 30.3% | $50.2 | (11.0)% | $177.5 | $148.7 | 19.4% |
| Net income - T. Rowe Price Group, Inc. | $547.1 | $484.8 | 12.9% | $631.7 | (13.4)% | $2194.9 | $2139.5 | 2.6% |
| Diluted earnings per common share | $2.44 | $2.12 | 15.1% | $2.81 | (13.2)% | $9.72 | $9.33 | 4.2% |
| **<u>Assets under management</u>** (in billions)<sup>(4)</sup> | **<u>Assets under management</u>** (in billions)<sup>(4)</sup> | **<u>Assets under management</u>** (in billions)<sup>(4)</sup> | **<u>Assets under management</u>** (in billions)<sup>(4)</sup> |  |  |  |  |  |
| Average assets under management | $1774.8 | $1638.6 | 8.3% | $1723 | 3.0% | $1677.3 | $1561.9 | 7.4% |
| Ending assets under management | $1775.6 | $1606.6 | 10.5% | $1767.2 | 0.5% | $1775.6 | $1606.6 | 10.5% |
| **<u>Investment advisory annualized effective fee rate (EFR)</u>** (in bps) | **<u>Investment advisory annualized effective fee rate (EFR)</u>** (in bps) | **<u>Investment advisory annualized effective fee rate (EFR)</u>** (in bps) |  |  |  |  |  |  |
| EFR without performance-based fees | 38.8 | 40.5 | (1.7) | 39.1 | (0.3) | 39.4 | 41.0 | (1.6) |
| EFR with performance-based fees | 39.2 | 40.9 | (1.7) | 39.3 | (0.1) | 39.6 | 41.4 | (1.8) |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.* <sup>(2)</sup> *Capital allocation-based income represents the change in accrued carried interest.* <sup>(3)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.* <sup>(4)</sup> *Beginning July 1, 2025, managed account - model delivery assets are included in assets under management.*

------

**Assets Under Management**<sup>(1)</sup>

During Q4 2025, assets under management (AUM) increased $8.4 billion to $1.8 trillion. The components of the change in AUM, by asset class, are shown in the table below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended 12/31/2025 | Three months ended 12/31/2025 | Three months ended 12/31/2025 | Three months ended 12/31/2025 | Three months ended 12/31/2025 |
| (in billions) | Equity | Fixed income, including money market | Multi-asset<sup>(2)</sup> | Alternatives<sup>(3)</sup> | Total |
| Assets under management at beginning of period | $885.4 | $208.1 | $617.7 | $56.0 | $1767.2 |
| Net cash flows prior to manager-driven distributions | (23.2) | 1.5 | (5.9) | 3.1 | (24.5) |
| Manager-driven distributions |  |  |  | (1.0) | (1.0) |
| Net cash flows | (23.2) | 1.5 | (5.9) | 2.1 | (25.5) |
| Net market appreciation (depreciation) and income<sup>(4)</sup> | 16.3 | 2.0 | 15.2 | 0.4 | 33.9 |
| Change during the period | (6.9) | 3.5 | 9.3 | 2.5 | 8.4 |
| Assets under management at December 31, 2025 | $878.5 | $211.6 | $627.0 | $58.5 | $1775.6 |

---

<sup>(1)</sup> *Includes assets in which T. Rowe Price and its affiliates have full discretionary authority along with managed account - model delivery assets.*

<sup>(2) &nbsp;&nbsp;&nbsp;&nbsp;</sup>*The underlying AUM of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.* 

<sup>(3)</sup> *The alternatives asset class includes strategies authorized to invest more than 50% of its holdings in private credit, leveraged loans, mezzanine, real assets/CRE, structured products, stressed/distressed, non-investment grade CLOs, special situations, business development companies, or that have absolute return as its investment objective. Generally, only those strategies with longer than daily liquidity are included. Unfunded capital commitments were $21.6 billion at December 31, 2025 and $22.0 billion as of September 30, 2025, and are not reflected in fee basis AUM above.*

<sup>(4)</sup> *Includes net distributions not reinvested of $5.5 billion.*

Investors domiciled outside the United States accounted for 8.8% of the firm's AUM at December 31, 2025, 8.7% at September 30, 2025 and 8.8% at December 31, 2024.

The firm provides participant accounting and plan administration for retirement plans that primarily invest in the firm's U.S. mutual funds, collective investment trusts, and funds managed outside of the firm's complex. As of December 31, 2025, the firm's assets under administration were $314 billion, of which $178 billion were assets the firm manages.

The firm's multi-asset investment division provides advisory solutions including investment insights, strategic asset allocation design, tactical asset allocation recommendations, and portfolio rebalancing services. The assets in these portfolios, predominantly in the United States, were $27.8 billion at December 31, 2025, compared with $25.2 billion at September 30, 2025.

------

**Financial Results Highlights**

**<u>Net Revenues</u>**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended | Three months ended | Three months ended | Three months ended | Three months ended |
| (in millions) | 12/31/2025 | 12/31/2024 | Change | 9/30/2025 | Change |
| Investment advisory fees |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $1029.1 | $1006.2 | 2.3% | $1011.8 | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 113.8 | 106.2 | 7.2% | 110.1 | 3.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 507.9 | 473.8 | 7.2% | 492.1 | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 86.8 | 81.0 | 7.2% | 84.7 | 2.5% |
| Total investment advisory fees | 1737.6 | 1667.2 | 4.2% | 1698.7 | 2.3% |
| Performance-based advisory fees | 14.2 | 19.3 | (26.4)% | 6.4 | 121.9% |
| Capital allocation-based income<sup>(1)</sup> | 40.8 | (5.2) | n/m | 42.0 | n/m |
| Administrative, distribution, services, and other fees | 141.5 | 143.2 | (1.2)% | 146.4 | (3.3)% |
| Net revenues | $1934.1 | $1824.5 | 6.0% | $1893.5 | 2.1% |
| **Average AUM (in billions):** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $886.1 | $842.7 | 5.2% | $865.8 | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 210.5 | 186.9 | 12.6% | 203.8 | 3.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 621.9 | 556.3 | 11.8% | 597.7 | 4.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 56.3 | 52.7 | 6.8% | 55.7 | 1.1% |
| Average AUM | $1774.8 | $1638.6 | 8.3% | $1723.0 | 3.0% |
| Investment advisory annualized effective fee rate (bps) | 38.8 | 40.5 | (1.7) | 39.1 | (0.3) |
| Investment advisory annualized effective fee rate, including performance-based fees (bps) | 39.2 | 40.9 | (1.7) | 39.3 | (0.1) |

---

<sup>(1)</sup> *The Capital allocation-based income represents the change in accrued carried interest. The percentage change is not meaningful (n/m).* 

**Net revenues** in Q4 2025 were $1.9 billion, an increase of 6.0% from Q4 2024 and 2.1% from Q3 2025. Performance-based fees earned in each period were primarily related to alternatives strategies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** The investment advisory annualized effective fee rate, excluding performance-based fees, of 38.8 basis points in Q4 2025 decreased from 40.5 basis points earned in Q4 2024 and 39.1 basis points earned in Q3 2025. In comparison to prior periods, client flows and transfers drove a mix shift in assets under management toward lower fee products and asset classes, partially offset by market appreciation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Capital allocation-based income impacted net revenues as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended | Three months ended | Three months ended | Three months ended | Three months ended |
| (in millions) | 12/31/2025 | 12/31/2024 | Change | 9/30/2025 | Change |
| Change in accrued carried interest | $47.6 | $12.5 | $35.1 | $56.2 | $(8.6) |
| Acquisition-related amortization and impairments | (6.8) | (17.7) | 10.9 | (14.2) | 7.4 |
| Capital allocation-based income | $40.8 | $(5.2) | $46.0 | $42.0 | $(1.2) |

---

The changes in accrued carried interest from Q4 2024 and Q3 2025 were driven by relative market performance. The decrease in acquisition-related amortization and impairments from Q4 2024 and Q3 2025 was primarily due to impairments recognized in prior periods that did not recur in the current period. A portion of capital allocation-based income is passed through as compensation, with unpaid amounts reported as non-controlling interest on the consolidated balance sheet. For detail on the quarterly changes

------

in accrued carried interest, which is reported as part of investments on the consolidated balance sheet, and related non-controlling interest, refer to the tables at the end of this release.

**<u>Operating Expenses</u>**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended | Three months ended | Three months ended | Three months ended | Three months ended |
| (in millions) | 12/31/2025 | 12/31/2024 | Change<sup>(1)</sup> | 9/30/2025 | Change<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;Compensation, benefits, and related costs | $705.1 | $705.4 | —% | $632.5 | 11.5% |
| &nbsp;&nbsp;&nbsp;Acquisition-related retention agreements | 14.2 | 14.2 | —% | 14.2 | —% |
| &nbsp;&nbsp;Capital allocation-based income compensation<sup>(2)</sup> | 15.9 | (3.4) | n/m | 16.8 | (5.4)% |
| &nbsp;&nbsp;&nbsp;Market-related change in deferred compensation liabilities | 26.4 | (6.7) | n/m | 50.8 | (48.0)% |
| Total compensation and related costs | 761.6 | 709.5 | 7.3% | 714.3 | 6.6% |
| Distribution and servicing | 101.6 | 92.9 | 9.4% | 95.8 | 6.1% |
| Advertising and promotion | 30.1 | 50.2 | (40.0)% | 21.3 | 41.3% |
| Product and recordkeeping related costs | 75.6 | 74.5 | 1.5% | 78.7 | (3.9)% |
| Technology, occupancy, and facility costs | 193.4 | 169.3 | 14.2% | 183.2 | 5.6% |
| General, administrative, and other | 127.4 | 128.3 | (0.7)% | 101.7 | 25.3% |
| Acquisition-related amortization and impairment costs | 24.6 | 31.4 | (21.7)% | 26.8 | (8.2)% |
| Restructuring charge | 148.8 |  | n/m | 28.5 | n/m |
| **Total operating expenses** | $1463.1 | $1256.1 | 16.5% | $1250.3 | 17.0% |
| **Total adjusted operating expenses**<sup>(3)</sup> | $1249.8 | $1222.6 | 2.2% | $1134.4 | 10.2% |

---

<sup>(1)</sup> *n/m - the percentage change is not meaningful.* 

<sup>(2)</sup> *Capital allocation-based income compensation represents the change in accrued carried interest compensation along with acquisition-related, non-cash amortization and impairments.*

<sup>(3)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.*

**Operating expenses** were $1,463.1 million, an increase of 16.5% from Q4 2024 and 17.0% from Q3 2025. **Adjusted operating expenses** in Q4 2025 were $1,249.8 million, an increase of 2.2% from Q4 2024 and 10.2% from Q3 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Compensation, benefits, and related costs in Q4 2025 of $705.1 million decreased $0.3 million from Q4 2024 and increased $72.6 million from Q3 2025. The decline from Q4 2024 was primarily due to lower salaries and related benefits, nearly offset by higher costs associated with the firm's annual long-term incentive grant. Compared to Q3 2025, the cost increase was primarily driven by the annual incentive grant in December, higher employee benefit costs, and a higher bonus accrual, partially offset by lower salaries. Each year, the level of the Q4 bonus accrual is driven by the total bonus pool awarded in December compared to the cumulative bonus expense accrued over the first three quarters of the year. The firm employed 7,773 associates as of December 31, 2025, a decrease of 4.7% from 8,158 associates as of December 31, 2024, and 0.7% from 7,830 associates as of September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Distribution and servicing costs in Q4 2025 of $101.6 million increased $8.7 million from Q4 2024 and $5.8 million from Q3 2025. The increases from prior periods were primarily driven by higher average assets under management distributed through third-party intermediaries.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Advertising and promotion expenses in Q4 2025 of $30.1 million decreased $20.1 million from Q4 2024 and increased $8.8 million from Q3 2025. The decrease from Q4 2024 was primarily due to reduced media spend and agency costs. Additionally, the seasonal nature of the spending contributed to the increase compared to Q3 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Technology, occupancy, and facility costs in Q4 2025 of $193.4 million increased $24.1 million from Q4 2024 and $10.2 million from Q3 2025. The increases from prior periods were due to higher technology costs, including depreciation and hosted solutions, and occupancy costs related to the firm's corporate headquarters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** General, administrative, and other costs in Q4 2025 of $127.4 million decreased $0.9 million from Q4 2024 and increased $25.7 million from Q3 2025. The increase from Q3 2025 was primarily due to higher professional fees, charitable contributions, travel and entertainment, and other administrative costs. The increase was further impacted by a cost recovery recorded in Q3 2025, which did not recur in Q4 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***▪*** Restructuring charge in Q4 2025 of $148.8 million relates to actions taken under the previously announced broad and ongoing expense management program, which will allow the firm to reduce expense growth and realign resources to support investment in existing and future capabilities. The charge includes accelerated depreciation and impairment charges related to certain owned real estate of $127.3 million as well as compensation-related costs, primarily severance.

------

**<u>Non-operating income (loss)</u>**

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | Three months ended | Three months ended | Three months ended |
|  | 12/31/2025 | 12/31/2024 | 9/30/2025 |
| Net gains (losses) from non-consolidated T. Rowe Price investment products |  |  |  |
| Cash and discretionary investments |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | $41.2 | $39.8 | $38.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 3.5 | (1.4) | 12.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net gains (losses) from cash and discretionary investments | **44.7** | **38.4** | **50.2** |
| Seed capital investments |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | 2.3 | 1.6 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 5.6 | 1.9 | 17.1 |
| Net gains (losses) recognized upon deconsolidation |  | 0.2 |  |
| Investments used to hedge deferred compensation liabilities | 29.6 | (9.2) | 53.0 |
| **Total net gains (losses) from non-consolidated T. Rowe Price investment products** | **82.2** | **32.9** | **120.8** |
| Other investment income (loss) | 23.7 | 11.8 | 40.4 |
| **Net gains (losses) on investments** | **105.9** | **44.7** | **161.2** |
| Net gains (losses) on consolidated investment products | 36.8 | (36.4) | 72.6 |
| Other gains (losses), including foreign currency gains (losses) | (0.6) | (3.7) | 4.6 |
| **Non-operating income (loss)** | $**142.1** | $**4.6** | $**238.4** |
| **Adjusted non-operating income (loss)**<sup>(1)</sup> | $**44.7** | $**34.3** | $**50.2** |

---

<sup>(1)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.*

On an adjusted basis, non-operating income (loss) consists of investment gains/losses generated from the firm's cash and discretionary investment portfolio.

**<u>Income taxes</u>** 

The following reconciles the statutory federal income tax rate to the firm's effective tax rate for the years ended December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Year ended** | **Year ended** |
| | **12/31/2025** | **12/31/2024** |
| Statutory U.S. federal income tax rate | 21.0% | 21.0% |
| State income taxes, net of federal income tax benefits | 2.1 | 2.9 |
| Net (income) losses attributable to redeemable non-controlling interests<sup>(1)</sup> | (0.9) | (0.3) |
| Net excess tax losses (benefits) from stock-based compensation plans activity |  | (0.1) |
| Valuation allowances | 0.4 | 0.2 |
| Other items | 0.6 | 0.6 |
| Effective income tax rate | 23.2% | 24.3% |
| Adjusted effective income tax rate | 24.3% | 24.5% |

---

<sup>(1)</sup> *Net income attributable to redeemable non-controlling interest represents the portion of earnings held in the firm's consolidated investment products, which are not taxable to the firm despite being included in pre-tax income.*

The 2025 U.S. GAAP and adjusted effective tax rates decreased compared to 2024, primarily due to lower state taxes resulting from prior period settlements. Additionally, the impact of redeemable non-controlling interest contributed to the lower U.S. GAAP effective tax rate compared to the 2024 period.

The firm estimates that its effective tax rate for the full year 2026 will be in the range of 23.0% to 27.0% on a U.S. GAAP basis, and 24.0% to 27.0% on an adjusted basis.

------

**Other Matters**

The financial results presented in this release are unaudited. KPMG LLP is currently completing its audits of the firm's 2025 consolidated financial statements and internal controls over financial reporting at December 31, 2025. The firm expects that KPMG will complete its work in the middle of February and will then file its Form 10-K Annual Report for 2025 with the U.S. Securities and Exchange Commission. The Form 10-K will include additional information, including the firm's audited consolidated financial statements, management's report on internal controls over financial reporting at December 31, 2025, and the KPMG reports.

Certain statements in this earnings release may represent "forward-looking information," including information relating to anticipated changes in revenues, our operations, expenses, earnings, liquidity, cash flows and capital expenditures, industry or market conditions, amount or composition of assets under management, flows into our investment funds, regulatory developments, changes in our effective fee rate, demand for and pricing of our products, new products and services, effective tax rates, net income and earnings per common share, future transactions, our strategic initiatives, general economic conditions, dividends, stock repurchases, and other market conditions. For a discussion concerning risks and other factors that could affect future results, see the firm's 2024 Annual Report on Form 10-K.

T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.78 trillion in client assets as of December 31, 2025, about two-thirds of which are retirement-related. Renowned for over 85 years of investment excellence, retirement leadership, and independent proprietary research, the firm leverages its longstanding expertise to ask better questions that can drive better investment decisions. Built on a culture of integrity and prioritizing client interests, T. Rowe Price empowers millions of investors worldwide to thrive amidst evolving markets. Visit troweprice.com/newsroom for news and public policy commentary.

**Webcast Information**

Chair, Chief Executive Officer, and President Rob Sharps, and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast on Wednesday, February 4, 2026 from 8:00 - 8:45 AM (Eastern Time). Eric Veiel, head of Global Investments, will join for the Q&A portion.

To access the webcast or to obtain dial in instructions to ask a question, please visit: investors.troweprice.com. Supplemental materials will be available on the company's investor relations website. A replay of the webcast will be available on the firm's investor relations website shortly after the event.

------

**T. ROWE PRICE CONTACTS:**

**Public Relations**

Lauren Dear

410-577-5009 <br>**lauren.dear@troweprice.com**

**Investor Relations**

Linsley Carruth

410-345-3717 <br>**linsley.carruth@troweprice.com**

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Unaudited Consolidated Statements of Income** | **Three months ended** | **Three months ended** | **Three months ended** | **Year ended** | **Year ended** |
| **(in millions, except per-share amounts)** | **12/31/2025** | **12/31/2024** | **9/30/2025** | **12/31/2025** | **12/31/2024** |
| **Revenues** | | | | | |
| &nbsp;&nbsp;&nbsp;Investment advisory fees | $1737.6 | $1667.2 | $1698.7 | $6602.3 | $6399.7 |
| &nbsp;&nbsp;&nbsp;Performance-based advisory fees | 14.2 | 19.3 | 6.4 | 37.4 | 59.3 |
| &nbsp;&nbsp;&nbsp;Capital allocation-based income | 40.8 | (5.2) | 42.0 | 81.2 | 46.6 |
| &nbsp;&nbsp;&nbsp;Administrative, distribution, services, and other fees | 141.5 | 143.2 | 146.4 | 593.9 | 588.0 |
| &nbsp;&nbsp;**Net revenues** | **1934.1** | **1824.5** | **1893.5** | **7314.8** | **7093.6** |
| **Operating expenses** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Compensation, benefits, and related costs | 705.1 | 705.4 | 632.5 | 2644.3 | 2603.4 |
| &nbsp;&nbsp;&nbsp;Acquisition-related retention agreements | 14.2 | 14.2 | 14.2 | 56.7 | 44.8 |
| &nbsp;&nbsp;&nbsp;Capital allocation-based income compensation | 15.9 | (3.4) | 16.8 | 30.8 | 5.4 |
| &nbsp;&nbsp;&nbsp;Market-related change in deferred compensation liabilities | 26.4 | (6.7) | 50.8 | 136.3 | 104.3 |
| &nbsp;&nbsp;&nbsp;Total compensation and related costs | 761.6 | 709.5 | 714.3 | 2868.1 | 2757.9 |
| &nbsp;&nbsp;&nbsp;Distribution and servicing costs | 101.6 | 92.9 | 95.8 | 383.5 | 354.1 |
| &nbsp;&nbsp;&nbsp;Advertising and promotion costs | 30.1 | 50.2 | 21.3 | 107.4 | 129.6 |
| &nbsp;&nbsp;&nbsp;Product and recordkeeping related costs | 75.6 | 74.5 | 78.7 | 312.9 | 297.5 |
| &nbsp;&nbsp;&nbsp;Technology, occupancy, and facility costs | 193.4 | 169.3 | 183.2 | 723.6 | 644.1 |
| &nbsp;&nbsp;&nbsp;General, administrative, and other costs | 127.4 | 128.3 | 101.7 | 441.9 | 433.8 |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration |  |  |  |  | (13.4) |
| &nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairment costs | 24.6 | 31.4 | 26.8 | 111.3 | 156.7 |
| &nbsp;&nbsp;&nbsp;Restructuring charge | 148.8 |  | 28.5 | 177.3 |  |
| &nbsp;&nbsp;**Total operating expenses** | **1463.1** | **1256.1** | **1250.3** | **5126.0** | **4760.3** |
| **Net operating income** | **471.0** | **568.4** | **643.2** | **2188.8** | **2333.3** |
| **Non-operating income** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net gains on investments | 105.9 | 44.7 | 161.2 | 464.9 | 363.2 |
| &nbsp;&nbsp;&nbsp;Net gains (losses) on consolidated investment products | 36.8 | (36.4) | 72.6 | 219.9 | 130.3 |
| &nbsp;&nbsp;&nbsp;Other gains (losses), including foreign currency gains (losses) | (0.6) | (3.7) | 4.6 | 1.9 | (7.2) |
| &nbsp;&nbsp;&nbsp;**Total non-operating income** | **142.1** | **4.6** | **238.4** | **686.7** | **486.3** |
| Income before income taxes | 613.1 | 573.0 | 881.6 | 2875.5 | 2819.6 |
| Provision for income taxes | 152.5 | 156.3 | 195.1 | 667.2 | 683.8 |
| Net income | 460.6 | 416.7 | 686.5 | 2208.3 | 2135.8 |
| &nbsp;&nbsp;&nbsp;Less: net income (loss) attributable to redeemable non-controlling interests | 15.3 | (23.2) | 40.4 | 121.2 | 35.7 |
| **Net income attributable to T. Rowe Price Group, Inc.** | **445.3** | **439.9** | **646.1** | **2087.1** | **2100.1** |
| &nbsp;&nbsp;&nbsp;Less: net income allocated to outstanding restricted stock and stock unit holders | **11.1** | **11.6** | **14.7** | **50.6** | **55.8** |
| **Net income allocated to T. Rowe Price common stockholders** | **434.2** | **428.3** | **631.4** | **2036.5** | **2044.3** |
| **Earnings per share on common stock of T. Rowe Price Group, Inc.** | **Earnings per share on common stock of T. Rowe Price Group, Inc.** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $1.99 | $1.93 | $2.88 | $9.26 | $9.18 |
| &nbsp;&nbsp;**Diluted** | $**1.99** | $**1.92** | $**2.87** | $**9.24** | $**9.15** |
| **Weighted-average common shares** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Outstanding | 218.2 | 222.4 | 219.4 | 220.0 | 222.8 |
| &nbsp;&nbsp;&nbsp;Outstanding assuming dilution | 218.4 | 222.8 | 219.7 | 220.3 | 223.3 |
| **Summary of Adjusted Basis**<sup>(1)</sup> | **Three months ended** | **Three months ended** | **Three months ended** | **Year ended** | **Year ended** |
| (in millions, except per-share data) | **12/31/2025** | **12/31/2024** | **9/30/2025** | **12/31/2025** | **12/31/2024** |
| Operating expenses | $1249.8 | $1222.6 | $1134.4 | $4666.5 | $4498.8 |
| Operating expenses, excluding accrued carried interest related compensation | $1231.1 | $1218.7 | $1111.8 | $4608.0 | $4456.3 |
| Net operating income | $691.7 | $620.2 | $774.1 | $2720.8 | $2685.9 |
| Non-operating income (loss) | $44.7 | $34.3 | $50.2 | $177.5 | $148.7 |
| Net income attributable to T. Rowe Price | $547.1 | $484.8 | $631.7 | $2194.9 | $2139.5 |
| Diluted earnings per common share | $2.44 | $2.12 | $2.81 | $9.72 | $9.33 |

---

<sup>(1)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.*

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Assets Under Management**<sup>(1)</sup> | Year ended 12/31/2025 | Year ended 12/31/2025 | Year ended 12/31/2025 | Year ended 12/31/2025 | Year ended 12/31/2025 |
| (in billions) | Equity | Fixed income, including money market | Multi-asset<sup>(2)</sup> | Alternatives<sup>(3)</sup> | Total |
| Assets under management at beginning of period | $829.7 | $188.1 | $536.0 | $52.8 | $1606.6 |
| Managed account - model delivery asset<sup>(4)</sup> | 9.2 |  |  |  | 9.2 |
| Net cash flows prior to manager-driven distributions | (74.9) | 12.5 | 1.8 | 6.9 | (53.7) |
| Manager-driven distributions |  |  |  | (3.2) | (3.2) |
| Net cash flows | (74.9) | 12.5 | 1.8 | 3.7 | (56.9) |
| Net market appreciation and gains<sup>(5)</sup> | 114.5 | 11.0 | 89.2 | 2.0 | 216.7 |
| Change during the period (net cash flows and market) | 39.6 | 23.5 | 91.0 | 5.7 | 159.8 |
| Assets under management at December 31, 2025 | $878.5 | $211.6 | $627.0 | $58.5 | $1775.6 |

---

<sup>(1)</sup> *Includes assets in which T. Rowe Price and its affiliates have full discretionary authority along with managed account - model delivery assets.*

<sup>(2) &nbsp;&nbsp;&nbsp;&nbsp;</sup>*The underlying AUM of the multi-asset portfolios have been aggregated and presented in this category and not reported in the equity and fixed income columns.* 

<sup>(3)</sup> *The alternatives asset class includes strategies authorized to invest more than 50% of its holdings in private credit, leveraged loans, mezzanine, real assets/CRE, structured products, stressed/distressed, non-investment grade CLOs, special situations, business development companies, or that have absolute return as its investment objective. Generally, only those strategies with longer than daily liquidity are included. Unfunded capital commitments were $21.6 billion as of December 31, 2025 and $16.2 billion as of December 31, 2024 and are not reflected in fee basis AUM above.*

<sup>(4)</sup> *Amount represents the net assets as of July 1, 2025, and all activity for the second half of 2025 is presented in the lines that follow.*

<sup>(5)</sup> *Includes net distributions not reinvested of $6.8 billion.*

---

| | | | |
|:---|:---|:---|:---|
| **Net Revenues** | Year ended | Year ended | Year ended |
| (in millions) | 12/31/2025 | 12/31/2024 | % Change |
| **Investment advisory fees** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $3923.7 | $3864.7 | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 433.0 | 410.7 | 5.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 1910.6 | 1814.1 | 5.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 335.0 | 310.2 | 8.0% |
| **Total investment advisory fees** | $**6602.3** | $**6399.7** | **3.2%** |
| **Average AUM (in billions):** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity | $840.9 | $804.3 | 4.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed income, including money market | 201.0 | 178.6 | 12.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-asset | 580.7 | 529.0 | 9.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Alternatives | 54.7 | 50.0 | 9.4% |
| **Average AUM** | $**1677.3** | $**1561.9** | **7.4%** |

---

---

| | | |
|:---|:---|:---|
| **Non-Operating Income (Loss)** | Year ended | Year ended |
| (in millions) | 12/31/2025 | 12/31/2024 |
| Net gains (losses) from non-consolidated investment products |  |  |
| &nbsp;&nbsp;&nbsp;Cash and discretionary investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | $143.5 | $138.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 33.1 | 4.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net gains (losses) from cash and discretionary investments | **176.6** | **143.4** |
| &nbsp;&nbsp;&nbsp;Seed capital investments |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividend income | 3.2 | 2.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Market-related gains (losses) and equity in earnings (losses) | 48.2 | 62.0 |
| &nbsp;&nbsp;&nbsp;Net gains (losses) recognized upon deconsolidation | 3.1 | (0.4) |
| &nbsp;&nbsp;&nbsp;Investments used to hedge deferred compensation liabilities | 142.4 | 96.4 |
| **Total net gains (losses) from non-consolidated investment products** | **373.5** | **303.8** |
| &nbsp;&nbsp;&nbsp;Other investment income (loss) | 91.4 | 59.4 |
| **Net gains (losses) on investments** | **464.9** | **363.2** |
| Net gains (losses) on consolidated investment portfolios | 219.9 | 130.3 |
| Other gains (losses), including foreign currency gains (losses) | 1.9 | (7.2) |
| **Non-operating income (loss)** | $**686.7** | $**486.3** |
| **Adjusted non-operating income (loss)**<sup>(1)</sup> | $**177.5** | $**148.7** |

---

<sup>(1)</sup> *See the reconciliation to the comparable U.S. GAAP measures at the end of this earnings release.*

------

The following table summarizes the cash flows for the year ended 2025 that are attributable to T. Rowe Price, our consolidated investment products, and the related eliminations required.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Year ended | Year ended | Year ended | Year ended |
| | 12/31/2025 | 12/31/2025 | 12/31/2025 | 12/31/2025 |
| (in millions) | Cash flow attributable to T. Rowe Price | Cash flow attributable to consolidated investment products | Elims | As reported |
| Cash flows from operating activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $2087.1 | $210.1 | $(88.9) | $2208.3 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, amortization and impairments of property, equipment and software | 405.8 |  |  | 405.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization and impairment of acquisition-related assets and retention agreements | 199.7 |  |  | 199.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 216.9 |  |  | 216.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (gains) losses recognized on investments | (541.3) |  | 88.9 | (452.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (investments) redemptions in sponsored investment products used to economically hedge deferred compensation liabilities | (64.6) |  | 72.6 | 8.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in trading securities held by consolidated investment products |  | (1002.7) |  | (1002.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other changes | 185.9 | (4.7) | (11.4) | 169.8 |
| Net cash provided by (used in) operating activities | 2489.5 | (797.3) | 61.2 | 1753.4 |
| Net cash provided by (used in) investing activities | 59.5 | (63.1) | 233.9 | 230.3 |
| Net cash provided by (used in) financing activities | (1820.6) | 838.3 | (295.1) | (1277.4) |
| Effect of exchange rate changes on cash and cash equivalents of consolidated investment products |  | (1.9) |  | (1.9) |
| Net change in cash and cash equivalents during year | 728.4 | (24.0) |  | 704.4 |
| Cash and cash equivalents at beginning of year | 2649.8 | 63.1 |  | 2712.9 |
| Cash and cash equivalents at end of year | $3378.2 | $39.1 | $— | $3417.3 |

---

---

| | | |
|:---|:---|:---|
| **Unaudited Condensed Consolidated Balance Sheet Information** | **As of** | **As of** |
| **(in millions)** | **12/31/2025** | **12/31/2024** |
| Cash and cash equivalents | $3378.2 | $2649.8 |
| Accounts receivable and accrued revenue | 931.2 | 877.4 |
| Investments | 3325.2 | 3000.5 |
| Assets of consolidated investment products | 1951.0 | 2044.0 |
| Operating lease assets | 382.9 | 226.8 |
| Property, equipment and software, net | 845.3 | 977.0 |
| Goodwill and intangible assets | 2917.0 | 3010.9 |
| Other assets | 611.0 | 685.6 |
| **Total assets** | **14341.8** | **13472.0** |
| Deferred compensation liabilities | 1176.8 | 1020.7 |
| Total other liabilities, includes $21.3 million at December 31, 2025 and $62.1 million at December 31, 2024, from consolidated investment products | 1111.8 | 1001.2 |
| Non-controlling interests\* | 1193.1 | 1104.7 |
| **Stockholders' equity attributable to T. Rowe Price Group, Inc., 218.6 common shares outstanding at December 31, 2025 and 223.0 common shares outstanding at December 31, 2024** | $**10860.1** | $**10345.4** |

---

*\* This includes both redeemable and non-redeemable non-controlling interest in consolidated entities.*

------

The following tables detail changes in our investments in affiliated private investment funds - carried interest and non-controlling interest in consolidated entities.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Investments in affiliated private investment funds - carried interest** | Three months ended | Three months ended | Three months ended | Year ended | Year ended |
| (in millions) | 12/31/2025 | 12/31/2024 | 9/30/2025 | 12/31/2025 | 12/31/2024 |
| Balance at beginning of period | $413.1 | $499.7 | $371.3 | $426.9 | $519.9 |
| Capital allocation-based income: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in accrued carried interest | 47.6 | 12.5 | 56.2 | 149.5 | 134.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairments | (6.8) | (17.7) | (14.2) | (68.3) | (87.5) |
| Net distributions | (63.6) | (67.6) | (0.2) | (117.8) | (139.6) |
| Balance at end of period | $390.3 | $426.9 | $413.1 | $390.3 | $426.9 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Non-controlling interests (NCI) in consolidated entities** | Three months ended | Three months ended | Three months ended | Year ended | Year ended |
| (in millions) | 12/31/2025 | 12/31/2024 | 9/30/2025 | 12/31/2025 | 12/31/2024 |
| Balance at beginning of period | $170.0 | $203.4 | $153.3 | $160.7 | $192.0 |
| Capital allocation-based income compensation: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in accrued carried interest compensation | 18.7 | 3.9 | 22.6 | 58.5 | 42.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related amortization and impairments | (2.8) | (7.3) | (5.8) | (27.7) | (37.1) |
| Net contributions (distributions) | (28.8) | (39.3) | (0.1) | (34.4) | (36.7) |
| Balance at end of period | $157.1 | $160.7 | $170.0 | $157.1 | $160.7 |

---

<u>Non-GAAP Information and Reconciliation</u>

The firm believes the non-GAAP financial measures below provide relevant and meaningful information to investors about its core operating results. These measures have been established in order to increase transparency for the purpose of evaluating the firm's core business, for comparing current results with prior period results, and to enable more appropriate comparison with industry peers. However, non-GAAP financial measures should not be considered as a substitute for financial measures calculated in accordance with U.S. GAAP and may be calculated differently by other companies.

------

The following schedules reconcile U.S. GAAP financial measures to non-GAAP financial measures for the three months ended December 31, 2025 and 2024 and September 30, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 12/31/2025** | **Three months ended 12/31/2025** | **Three months ended 12/31/2025** | **Three months ended 12/31/2025** | **Three months ended 12/31/2025** | **Three months ended 12/31/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1463.1 | $471.0 | $142.1 | $152.5 | $445.3 | $1.99 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 2.8 | 4.0 |  | 1.0 | 3.0 | 0.01 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 3.7 | 10.5 | 0.04 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (24.6) | 24.6 |  | 6.6 | 18.0 | 0.08 |
| Total acquisition-related | (36.0) | 42.8 |  | 11.3 | 31.5 | 0.13 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (26.4) | 26.4 | (29.6) | (0.8) | (2.4) | (0.01) |
| Restructuring charge<sup>(3)</sup> | (148.8) | 148.8 |  | 39.5 | 109.3 | 0.49 |
| Consolidated investment products<sup>(4)</sup> | (2.1) | 2.7 | (36.8) | (5.0) | (13.8) | (0.06) |
| Other non-operating income<sup>(5)</sup> |  |  | (31.0) | (8.2) | (22.8) | (0.10) |
| **Adjusted Basis** | $1249.8 | $691.7 | $44.7 | $189.3 | $547.1 | $2.44 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 12/31/2024** | **Three months ended 12/31/2024** | **Three months ended 12/31/2024** | **Three months ended 12/31/2024** | **Three months ended 12/31/2024** | **Three months ended 12/31/2024** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1256.1 | $568.4 | $4.6 | $156.3 | $439.9 | $1.92 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 7.3 | 10.4 |  | 2.4 | 8.0 | 0.04 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 3.3 | 10.9 | 0.04 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (31.4) | 31.4 |  | 7.2 | 24.2 | 0.11 |
| Total acquisition-related | (38.3) | 56.0 |  | 12.9 | 43.1 | 0.19 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | 6.7 | (6.7) | 9.2 | 0.6 | 1.9 | 0.01 |
| Consolidated investment products<sup>(4)</sup> | (1.9) | 2.5 | 36.4 | 3.6 | 12.1 | 0.05 |
| Other non-operating income<sup>(5)</sup> |  |  | (15.9) | (3.7) | (12.2) | (0.05) |
| **Adjusted Basis** | $1222.6 | $620.2 | $34.3 | $169.7 | $484.8 | $2.12 |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** | **Three months ended 9/30/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $1250.3 | $643.2 | $238.4 | $195.1 | $646.1 | $2.87 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 5.8 | 8.4 |  | 1.2 | 7.2 | 0.03 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (14.2) | 14.2 |  | 2.1 | 12.1 | 0.05 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (26.8) | 26.8 |  | 3.9 | 22.9 | 0.10 |
| Total acquisition-related | (35.2) | 49.4 |  | 7.2 | 42.2 | 0.18 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (50.8) | 50.8 | (53.0) | (0.3) | (1.9) | (0.01) |
| Restructuring charge<sup>(3)</sup> | (28.5) | 28.5 |  | 4.2 | 24.3 | 0.11 |
| Consolidated investment products<sup>(4)</sup> | (1.4) | 2.2 | (72.6) | (4.4) | (25.6) | (0.11) |
| Other non-operating income<sup>(5)</sup> |  |  | (62.6) | (9.2) | (53.4) | (0.23) |
| **Adjusted Basis** | $1134.4 | $774.1 | $50.2 | $192.6 | $631.7 | $2.81 |

---

The following schedules reconcile certain U.S. GAAP financial measures for the year ended December 31, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year ended 12/31/2025** | **Year ended 12/31/2025** | **Year ended 12/31/2025** | **Year ended 12/31/2025** | **Year ended 12/31/2025** | **Year ended 12/31/2025** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $5126.0 | $2188.8 | $686.7 | $667.2 | $2087.1 | $9.24 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 27.7 | 40.6 |  | 8.7 | 31.9 | 0.14 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (56.7) | 56.7 |  | 12.1 | 44.6 | 0.20 |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (111.3) | 111.3 |  | 23.7 | 87.6 | 0.39 |
| &nbsp;&nbsp;&nbsp;Total acquisition-related | (140.3) | 208.6 |  | 44.5 | 164.1 | 0.73 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (136.3) | 136.3 | (142.4) | (1.4) | (4.7) | (0.02) |
| Restructuring charge<sup>(3)</sup> | (177.3) | 177.3 |  | 43.6 | 133.7 | 0.59 |
| Consolidated investment products<sup>(4)</sup> | (5.6) | 9.8 | (219.9) | (21.0) | (67.9) | (0.30) |
| Other non-operating income<sup>(5)</sup> |  |  | (146.9) | (29.5) | (117.4) | (0.52) |
| **Adjusted Basis** | $4666.5 | $2720.8 | $177.5 | $703.4 | $2194.9 | $9.72 |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year ended 12/31/2024** | **Year ended 12/31/2024** | **Year ended 12/31/2024** | **Year ended 12/31/2024** | **Year ended 12/31/2024** | **Year ended 12/31/2024** |
| | **Operating expenses** | **Net operating income** | **Non-operating income (loss)** | **Provision (benefit) for income taxes**<sup>(6)</sup> | **Net income attributable to T. Rowe Price Group, Inc.** | **Diluted earnings per share**<sup>(7)</sup> |
| **U.S. GAAP Basis (FS line item)** | $4760.3 | $2333.3 | $486.3 | $683.8 | $2100.1 | $9.15 |
| Non-GAAP adjustments: |  |  |  |  |  |  |
| Acquisition-related: |  |  |  |  |  |  |
| &nbsp;&nbsp;Investment and NCI amortization and impairments<sup>(1)</sup> (Capital allocation-based income and Compensation and related costs) | 37.1 | 50.4 |  | 10.2 | 40.2 | 0.18 |
| &nbsp;&nbsp;Acquisition-related retention arrangements<sup>(1)</sup> (Compensation and related costs) | (44.8) | 44.8 |  | 10.4 | 34.4 | 0.15 |
| &nbsp;&nbsp;Contingent consideration<sup>(1)</sup> | 13.4 | (13.4) |  | (1.8) | (11.6) | (0.05) |
| &nbsp;&nbsp;Intangible assets amortization and impairments<sup>(1)</sup> | (156.7) | 156.7 |  | 32.2 | 124.5 | 0.54 |
| &nbsp;&nbsp;&nbsp;Total acquisition-related | (151.0) | 238.5 |  | 51.0 | 187.5 | 0.82 |
| Deferred compensation liabilities<sup>(2)</sup> (Compensation and related costs) | (104.3) | 104.3 | (96.4) | 1.7 | 6.2 | 0.03 |
| Consolidated investment products<sup>(4)</sup> | (6.2) | 9.8 | (130.3) | (17.5) | (67.3) | (0.29) |
| Other non-operating income<sup>(5)</sup> |  |  | (110.9) | (23.9) | (87.0) | (0.38) |
| **Adjusted Basis** | $4498.8 | $2685.9 | $148.7 | $695.1 | $2139.5 | $9.33 |

---

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;These non-GAAP adjustments remove the impact of acquisition-related amortization of intangible assets, the recurring fair value remeasurements of the contingent consideration liability, if any, amortization of acquired investment and non-controlling interest basis differences and amortization of compensation-related arrangements. The firm believes adjusting for these charges helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment eliminates the compensation expense impact from market valuation changes in deferred compensation liabilities, including the supplemental savings plan and, starting in Q4 2024, restricted fund units, and the related net gains (losses) on investments used as economic hedges against the related liabilities. The liabilities are adjusted based on the performance of hypothetical investments selected by participants. The firm uses investment products to economically hedge the market risk associated with the supplemental savings plan liability and the expected settlement value of unvested restricted fund units. The firm believes it is useful to offset the non-operating investment income (loss) of the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes accelerated depreciation and impairment charges related to certain owned real estate, as well as compensation expenses, primarily severance, resulting from actions taken as part of the firm's broad, ongoing plan to reduce expense growth and realign resources to support existing and future capabilities.The firm believes this adjustment helps the reader's ability to understand the firm's core operating results and increases comparability period to period.

<sup>(4)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes the impact of the consolidated investment products by adding back their operating expenses and subtracting their investment income. The operating expense adjustment represents their operating expenses net of related investment advisory and administrative fees. The adjustment to net income attributable to T. Rowe Price Group, Inc. represents the consolidated investment products' net income, net of redeemable non-controlling interests. The firm believes this adjustment helps the reader's ability to understand our core operating results and increases comparability period to period.

<sup>(5)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP adjustment removes non-operating income (loss) earned on those investments that are not economic hedges for the deferred compensation liabilities and are not part of the cash and discretionary investment portfolio. The firm retain gains from cash and discretionary investments in our non-GAAP measures, as they are considered part of our core operations. The firm believes adjusting for the remaining non-operating income (loss) helps the reader's ability to understand the firm's core operating results and increases comparability period to period. Additionally, the firm does not emphasize this portion of non-operating income (loss) when assessing the firm's performance.

<sup>(6)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 24.3% in 2025 and 24.5% in 2024. As such, the non-GAAP effective tax rate for the three months ended December 31, 2025 and 2024 was 25.7% and 25.9%, respectively.

------

<sup>(7)</sup> &nbsp;&nbsp;&nbsp;&nbsp;This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group, Inc. and dividing by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Year ended** | **Year ended** |
| | **12/31/2025** | **12/31/2024** | **9/30/2025** | **12/31/2025** | **12/31/2024** |
| Adjusted net income attributable to T. Rowe Price | $547.1 | $484.8 | $631.7 | $2194.9 | $2139.5 |
| Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 13.6 | 12.7 | 14.3 | 53.3 | 56.8 |
| Adjusted net income allocated to common stockholders | $533.5 | $472.1 | $617.4 | $2141.6 | $2082.7 |

---

<br>